Thermo Fisher partners EDB for US$130m sterile fill-and-finish facility
Singapore
THERMO Fisher Scientific's plans to build a new US$130 million sterile fill-and-finish facility in Singapore, with the support of the Singapore Economic Development Board (EDB), will create some 300 jobs once operational in 2022.
The investment is an "important addition to the manufacturing capacity needed by global pharmaceutical and vaccine companies in the ongoing fight against Covid-19," EDB chairman Beh Swan Gin said in a press release late last week.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
International
US official urges China, Russia to declare only humans, not AI, control nuclear weapons
Banking giants race to Riyadh as MBS steps up pressure campaign
Biden now calls ally Japan ‘xenophobic’ along with China, Russia
Japanese companies struggle with yen’s continued weakness
Australia’s March goods trade surplus narrows to more than 3-year low
Hong Kong holds rate as Fed signals inflation concerns